Buprenorphine And Naloxone 31722-0851
Product NDC
31722-0851- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- January 5, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219727
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE (31722-851-30)